Lvm Capital Management LTD Vertex Pharmaceuticals Inc Transaction History
Lvm Capital Management LTD
- $929 Million
- Q4 2024
A detailed history of Lvm Capital Management LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Lvm Capital Management LTD holds 30,383 shares of VRTX stock, worth $13.8 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
30,383
Previous 30,013
1.23%
Holding current value
$13.8 Million
Previous $14 Million
12.34%
% of portfolio
1.32%
Previous 1.61%
Shares
16 transactions
Others Institutions Holding VRTX
# of Institutions
1,717Shares Held
223MCall Options Held
1.64MPut Options Held
1.37M-
Capital World Investors Los Angeles, CA26.8MShares$12.2 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.6 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.38 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.1 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $117B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...